Last checked September 2026 against 12 sources · Editorial policy
Peptides for menopause
No peptide is FDA-approved to treat menopause symptoms. The approved peptide drugs relevant to midlife women are GLP-1 medicines such as semaglutide and tirzepatide for weight. Popular 'wellness' peptides such as BPC-157, CJC-1295, ipamorelin and MOTs-C aren't approved, and the FDA says it lacks safety information or has identified serious risks for them. Oral collagen peptides improved skin hydration and elasticity in trials.
No peptide is approved for menopause symptoms. GLP-1s for weight, oral collagen for skin, and why the FDA flags BPC-157, CJC-1295 and ipamorelin as safety risks.
Peptides for menopause: expectation vs reality
What people often expect
“Peptide injections are a natural, safe way to rebalance hormones in perimenopause”
What the evidence shows
Most peptides sold online or through wellness clinics are unapproved experimental drugs with no established human safety profile. Risks include contamination, impurities, wrong doses and hormonal overstimulation. None has been shown to treat hot flashes or other menopause symptoms.
Peptides and menopause: what's real and what's hype
Approved peptide drugs
Some peptides are evidence-based, FDA-approved medicines. Semaglutide (Wegovy) and tirzepatide (Zepbound) are approved for long-term weight management in adults with obesity, or overweight with a weight-related condition, and offer significant benefits under medical supervision. They don't treat hot flashes.
Learn more →BPC-157, CJC-1295 and other wellness peptides
The FDA placed BPC-157, CJC-1295, ipamorelin, epitalon, MOTs-C and other peptides on its list of bulk substances that may present significant safety risks in compounding. For BPC-157, it found no or only limited safety information. For CJC-1295, it identified serious adverse events, including increased heart rate and a vasodilatory reaction.
Growth hormone peptides
Peptides such as ipamorelin, GHRP-2, GHRP-6 and ibutamoren are promoted for muscle, fat loss and anti-aging. The FDA warns of immunogenicity and impurity risks, and ibutamoren may cause congestive heart failure in certain patients. A 2026 review warned these unregulated injectables can cause cardiovascular stress and supraphysiological hormone signaling.
Kisspeptin peptides and hormone claims
Kisspeptin is promoted for hormone balance, but the FDA says it has no or only limited safety information for compounded kisspeptin-10 and can't tell whether it would cause harm. There's no evidence in our sources that any peptide restores estrogen or progesterone in perimenopause.
Learn more →Peptides for low libido
Bremelanotide (Vyleesi) is a peptide injection approved for acquired low sexual desire in premenopausal women, used as needed at least 45 minutes before sex. Its label says it isn't indicated for postmenopausal women. Melanotan II, a related unapproved peptide, has been linked to melanoma and other serious adverse events.
Learn more →Collagen peptides for skin
Oral hydrolyzed collagen is a different product: a food supplement, not an injection. A meta-analysis of 26 randomized trials with 1,721 people found collagen significantly improved skin hydration and elasticity vs placebo, though the trials had several biases and larger studies are needed.
Learn more →Menopause peptides by the numbers
0
26
1.75 mg
28 days
Unapproved peptides aren't reviewed by the FDA for safety, effectiveness or quality.
Which peptides have evidence in menopause
FDA-approved GLP-1 peptides
Strong evidenceSemaglutide and tirzepatide for weight management with obesity, under medical supervision.
Related guide →Oral collagen peptides
Some evidenceImproved skin hydration and elasticity in trials; larger studies are needed.
Bremelanotide (Vyleesi), a libido peptide
If this is the causeFor low sexual desire before menopause only; not indicated after menopause.
HRT for menopause symptoms
First stepThe most effective treatment for hot flashes, unlike any peptide.
Related guide →Unapproved peptides: BPC-157, CJC-1295, ipamorelin, MOTs-C
No good evidenceUnapproved; the FDA lists them as potential significant safety risks in compounding.
When to talk to a doctor about peptides
Urgent: Chest pain, racing heart or fainting after a peptide injection
Get emergency help; call 911.
Redness, swelling or a lump at an injection site
See a doctor; contaminated products can cause reactions.
Low libido after menopause
Ask about treatments approved for postmenopausal women, such as testosterone or vaginal therapies.
More →
Peptides for menopause: questions women ask
What are the best peptides for menopause?
No peptide is approved to treat menopause symptoms. GLP-1 peptides are approved for weight, and oral collagen may help skin hydration and elasticity.
Are peptides safe for perimenopause?
Unapproved injectable peptides lack established human safety profiles, and the FDA lists many as potential significant safety risks.
Is BPC-157 safe for women?
The FDA says it has no or only limited safety information on BPC-157 and can't tell whether it would cause harm.
Do peptides help hot flashes?
No peptide has been shown to treat hot flashes. HRT is the most effective treatment, with non-hormonal medicines as alternatives.
Does collagen help menopause skin?
Oral collagen improved skin hydration and elasticity in a meta-analysis of 26 trials, though the trials had biases.
Can I take Vyleesi after menopause?
Its label says it isn't indicated for postmenopausal women; it's approved only for premenopausal women with low sexual desire.
What is BPC-157 used for?
It's promoted for tissue repair, inflammation and healthy aging, but it isn't FDA-approved, and the FDA says it has no or only limited safety information on it.
Is Ozempic a peptide?
Yes. Semaglutide and tirzepatide are FDA-approved peptide drugs for weight management, used under medical supervision; they don't treat hot flashes.
Can peptides raise estrogen in menopause?
No peptide has been shown to restore estrogen. Hormone therapy is the proven way to replace it and the most effective hot flash treatment.
Sources
- Moiz A, O'Keefe EL, O'Keefe JH. Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs. Mo Med. 2026;123(4):337-343.
- Wegovy (semaglutide). US prescribing information, DailyMed.
- US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks.
- Pu SY, Huang YL, Pu CM, et al. Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis. Nutrients. 2023;15(9):2080.
- Zepbound (tirzepatide). US prescribing information, DailyMed.
- Vyleesi (bremelanotide). US prescribing information, DailyMed.
- FDA. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
- The North American Menopause Society. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023;30(6):573-590.
- NHS. Heart palpitations.
- Islam RM, Bell RJ, Green S, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754-766.
- Prescribing information: Intrarosa (prasterone vaginal inserts). Millicent, 2026. DailyMed, US National Library of Medicine.
- Willis J, Vu N. Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards. Int J Pharm Compd. 2026;30(4):329-336.
See our editorial policy.
Related guides
GLP-1 drugs and menopause
Semaglutide and tirzepatide in menopause: who qualifies, what the limited evidence shows, weight loss with HRT…
Testosterone for women in perimenopause and menopause
Testosterone has evidence for low sexual desire after menopause, not for energy or mood. Who it's for, doses, …
Best menopause supplements
Menopause supplements rated by evidence: black cohosh and soy isoflavones help hot flashes modestly, vitamin D…
Menopause skin
Skin collagen and thickness fall by 1–2% a year after menopause. Why skin gets dry and thin, and what has real…